Jiaxin B. Wu
No. 2699, Qianjin Street
Changchun, 130012, China
Changchun, 130012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
A DNA Vaccine Incorporating the MHC Class I Trafficking Domain and PADRE Epitope Enhances Antitumor Immunity in a Murine Pancreatic Cancer Model.
Journal: International journal of molecular sciences
Published: January 13, 2026
Corrigendum to "Comparative study on the redox-responsive properties and antitumor efficacy of polyurethane nanocarriers with monosulfide, disulfide, and trisulfide bonds" [Journal of Controlled Release 385 (2025) 114035].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 23, 2025
Martensitic Transformation Mechanism In Situ Observation for the Simulated Coarse-Grained Heat-Affected Zone of DP1180 Steel.
Journal: Materials (Basel, Switzerland)
Published: May 07, 2025
Comparative study on the redox-responsive properties and antitumor efficacy of polyurethane nanocarriers with mono-, Di-, and trisulfide bonds.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 23, 2025
CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model.
Journal: Cancer immunology, immunotherapy : CII
Published: September 05, 2024
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection.
Journal: AIDS (London, England)
Published: August 21, 2024
The host restriction factor SERINC5 inhibits HIV-1 transcription by negatively regulating NF-κB signaling.
Journal: The Journal of biological chemistry
Published: August 09, 2024
Antitumor Effect and Immunomodulatory Mechanism of "Oncolytic Extracellular Vesicles".
Journal: Nano letters
Published: June 26, 2024
hmLIGHT Enhances Vaccine Antitumor Effects by Facilitating T-cell Infiltration and Activation in the 4T1 Breast Cancer Model.
Journal: Molecular cancer therapeutics
Published: May 09, 2024
Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs.
Journal: International immunopharmacology
Published: April 22, 2024
The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model.
Journal: International journal of molecular sciences
Published: December 05, 2023
Last Updated: 09/26/2026